Medunik USA expands Siklos® (hydroxyurea) coverage under Medicaid Programs to 37 states
PRINCETON, N.J., July 22, 2025 /PRNewswire/ – Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs and part of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life Sciences Innovation Award by ADRIQ, is pleased to announce that public reimbursement for Siklos® (hydroxyurea) under Medicaid Programs is now
Medunik USA expands Siklos® (hydroxyurea) coverage under Medicaid Programs to 37 states Read Post »
Press







